异动解读 | 吉利德科学业绩超预期 盘中股价大涨6.76%

异动解读
08 Nov 2024

2024年11月7日,生物医药公司吉利德科学股价盘中大涨6.76%,引发市场高度关注。

此前,吉利德公布了2024年第三季度财报,营收同比增长7%至75.5亿美元,超出分析师预期。调整后每股收益2.02美元,亦高于市场平均预期水平。

由于药品销售强劲增长,吉利德上调了2024年全年业绩指引,预计全年营收将在278亿至281亿美元区间,调整后每股收益区间则从原3.6至3.9美元提高至4.25至4.45美元,均超出了此前的指引区间和市场预期。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10